<DOC>
<DOCNO>
EP-0011854
</DOCNO>
<TEXT>
<DATE>
19800611
</DATE>
<IPC-CLASSIFICATIONS>
<main>C07D-213/74</main> A61K-31/4418 A61P-25/00 C07D-213/74 A61P-25/04 C07D-213/00 A61K-31/4402 A61K-31/44 A61P-29/00 
</IPC-CLASSIFICATIONS>
<TITLE>
4-(2'-pyridylamino)-phenylacetic acid derivatives, process for their preparation, pharmaceuticals containing these compounds and their use.
</TITLE>
<APPLICANT>
dainippon pharmaceutical cojp  <sep>dainippon pharmaceutical co., ltd.<sep>dainippon pharmaceutical co., ltd.25, doshomachi 3-chome higashi-kuosaka-shi, osaka 541jp<sep>dainippon pharmaceutical co., ltd.<sep>
</APPLICANT>
<INVENTOR>
hino katsuhiko<sep>nagai yasutaka<sep>nakamura hideo<sep>uno hitoshi<sep>hino, katsuhiko<sep>nagai, yasutaka<sep>nakamura, hideo<sep>uno, hitoshi<sep>hino, katsuhiko8-12-57, kasamatsu 1-chomeizumisano-shi (osaka)jp<sep>nagai, yasutaka49, minamikoji, kamiueno-chomuko-shi (kyoto)jp<sep>nakamura, hideo449-65, oji-chotenri-shi (nara)jp<sep>uno, hitoshi11-15, hiyoshidai sanban-chotakatsuki-shi (osaka)jp<sep>hino, katsuhiko<sep>nagai, yasutaka <sep>nakamura, hideo<sep>uno, hitoshi  <sep>hino, katsuhiko8-12-57, kasamatsu 1-chomeizumisano-shi (osaka)jp<sep>nagai, yasutaka49, minamikoji, kamiueno-chomuko-shi (kyoto)jp<sep>nakamura, hideo449-65, oji-chotenri-shi (nara)jp<sep>uno, hitoshi11-15, hiyoshidai sanban-chotakatsuki-shi (osaka)jp<sep>
</INVENTOR>
<ABSTRACT>
the invention relates to novel 4-(2′-pyridylamino)­ -phenylacetic acid derivatives of the formula i  wherein r₁ is hydrogen, a halogen, a lower alkyl having 1  to 3 carbon atoms, or nitro, r₂ is hydrogen, a halogen, or a  lower alkyl having 1 to 3 carbon atoms, r₃ is hydrogen, a  halogen, or a lower alkyl having 1 to 3 carbon atoms, r₄ is  hydrogen or a lower alkyl having 1 to 3 carbon atoms, r₅ is  hydrogen or -ch₂ch₂or₆ wherein r₆ is lower alkyl having 2 or  3 carbon atoms and being substituted with 1 or 2 hydroxy  groups, provided that r₁ or r₂ is not 4-halogen,   or pharmaceutically acceptable salts thereof, a process  for their preparation (e. g.  2-[4-(2′-pyridylamino)pehnyl] prop­ ionic acid (compound a) is prepared by reacting methyl 2-­ (4-amino -phenyl)propionate with 2-chloropyridine, followed  by hydrolysis), pharmaceutcial composition containing these  compounds, and their use as anti-inflammatory and analgesic  agents.  they have excellent anti-inflammatory and analgesic  activities with an extremely weak ulcerogenicity in the gas­ trointestinal tract.  some of the compounds have superior  inhibitory activity against chronic inflammation mediated by  cellular immunity.  in the figure the prophylactic effect on adjuvant-induced  arthritis in rats is shown (vehicle control (line 1), reference  compound ibuprofen (line 2), new compound a (line 3)].  
</ABSTRACT>
</TEXT>
</DOC>
